MEDLINE INC-CL A (MDLN) Fundamental Analysis & Valuation

NASDAQ:MDLN • US58507V1070

Current stock price

47.93 USD
-0.33 (-0.68%)
Last:

This MDLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDLN Profitability Analysis

1.1 Basic Checks

  • MDLN had positive earnings in the past year.
  • In the past year MDLN had a positive cash flow from operations.
MDLN Yearly Net Income VS EBIT VS OCF VS FCFMDLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • With a decent Return On Assets value of 3.01%, MDLN is doing good in the industry, outperforming 74.87% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 10.79%, MDLN belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
  • MDLN has a Return On Invested Capital of 4.86%. This is in the better half of the industry: MDLN outperforms 74.87% of its industry peers.
  • MDLN had an Average Return On Invested Capital over the past 3 years of 4.55%. This is below the industry average of 9.12%.
  • The last Return On Invested Capital (4.86%) for MDLN is above the 3 year average (4.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.01%
ROE 10.79%
ROIC 4.86%
ROA(3y)2.33%
ROA(5y)N/A
ROE(3y)6.48%
ROE(5y)N/A
ROIC(3y)4.55%
ROIC(5y)N/A
MDLN Yearly ROA, ROE, ROICMDLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • MDLN has a better Profit Margin (4.08%) than 76.47% of its industry peers.
  • The Operating Margin of MDLN (7.79%) is better than 74.87% of its industry peers.
  • In the last couple of years the Operating Margin of MDLN has grown nicely.
  • Looking at the Gross Margin, with a value of 26.44%, MDLN is doing worse than 77.54% of the companies in the same industry.
  • MDLN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.79%
PM (TTM) 4.08%
GM 26.44%
OM growth 3Y26.77%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5YN/A
MDLN Yearly Profit, Operating, Gross MarginsMDLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MDLN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDLN is destroying value.
  • MDLN has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MDLN has been reduced compared to a year ago.
MDLN Yearly Shares OutstandingMDLN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 200M 400M 600M 800M 1B
MDLN Yearly Total Debt VS Total AssetsMDLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • MDLN has an Altman-Z score of 2.55. This is not the best score and indicates that MDLN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MDLN's Altman-Z score of 2.55 is fine compared to the rest of the industry. MDLN outperforms 65.78% of its industry peers.
  • MDLN has a debt to FCF ratio of 9.68. This is a negative value and a sign of low solvency as MDLN would need 9.68 years to pay back of all of its debts.
  • The Debt to FCF ratio of MDLN (9.68) is better than 71.66% of its industry peers.
  • MDLN has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
  • MDLN's Debt to Equity ratio of 1.16 is on the low side compared to the rest of the industry. MDLN is outperformed by 78.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 9.68
Altman-Z 2.55
ROIC/WACC0.59
WACC8.2%
MDLN Yearly LT Debt VS Equity VS FCFMDLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.29 indicates that MDLN has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.29, MDLN is in the better half of the industry, outperforming 67.91% of the companies in the same industry.
  • A Quick Ratio of 2.37 indicates that MDLN has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.37, MDLN is in line with its industry, outperforming 56.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.29
Quick Ratio 2.37
MDLN Yearly Current Assets VS Current LiabilitesMDLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MDLN Growth Analysis

3.1 Past

  • MDLN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.87%.
  • The Revenue has grown by 11.47% in the past year. This is quite good.
  • MDLN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.85% yearly.
EPS 1Y (TTM)-4.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y9.85%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 16.14% on average over the next years. This is quite good.
  • MDLN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.38% yearly.
EPS Next Y22.1%
EPS Next 2Y17.47%
EPS Next 3Y16.14%
EPS Next 5YN/A
Revenue Next Year9.77%
Revenue Next 2Y8.72%
Revenue Next 3Y8.38%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MDLN Yearly Revenue VS EstimatesMDLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
MDLN Yearly EPS VS EstimatesMDLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. MDLN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 37.45, which means the current valuation is very expensive for MDLN.
  • MDLN's Price/Earnings ratio is a bit cheaper when compared to the industry. MDLN is cheaper than 70.05% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.95, MDLN is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 31.96, MDLN can be considered very expensive at the moment.
  • 71.66% of the companies in the same industry are more expensive than MDLN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. MDLN is around the same levels.
Industry RankSector Rank
PE 37.45
Fwd PE 31.96
MDLN Price Earnings VS Forward Price EarningsMDLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDLN is valued a bit cheaper than the industry average as 73.26% of the companies are valued more expensively.
  • MDLN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLN is cheaper than 72.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 48.55
EV/EBITDA 22.95
MDLN Per share dataMDLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • MDLN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • MDLN's earnings are expected to grow with 16.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.69
PEG (5Y)N/A
EPS Next 2Y17.47%
EPS Next 3Y16.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDLN Dividend Analysis

5.1 Amount

  • MDLN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDLN Fundamentals: All Metrics, Ratios and Statistics

MEDLINE INC-CL A

NASDAQ:MDLN (4/21/2026, 1:12:09 PM)

47.93

-0.33 (-0.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners52.66%
Inst Owner Change0.28%
Ins Owners0.16%
Ins Owner Change-6.03%
Market Cap62.97B
Revenue(TTM)28.43B
Net Income(TTM)1.16B
Analysts83.64
Price Target54.63 (13.98%)
Short Float %5.08%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.19%
PT rev (3m)N/A
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.49%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 37.45
Fwd PE 31.96
P/S 2.21
P/FCF 48.55
P/OCF 36.1
P/B 5.86
P/tB N/A
EV/EBITDA 22.95
EPS(TTM)1.28
EY2.67%
EPS(NY)1.5
Fwd EY3.13%
FCF(TTM)0.99
FCFY2.06%
OCF(TTM)1.33
OCFY2.77%
SpS21.64
BVpS8.17
TBVpS-8.55
PEG (NY)1.69
PEG (5Y)N/A
Graham Number15.3423 (-67.99%)
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 10.79%
ROCE 6.15%
ROIC 4.86%
ROICexc 5.14%
ROICexgc 14.47%
OM 7.79%
PM (TTM) 4.08%
GM 26.44%
FCFM 4.56%
ROA(3y)2.33%
ROA(5y)N/A
ROE(3y)6.48%
ROE(5y)N/A
ROIC(3y)4.55%
ROIC(5y)N/A
ROICexc(3y)4.71%
ROICexc(5y)N/A
ROICexgc(3y)14.23%
ROICexgc(5y)N/A
ROCE(3y)5.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y26.77%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5YN/A
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 9.68
Debt/EBITDA 3.87
Cap/Depr 44.21%
Cap/Sales 1.57%
Interest Coverage 2.35
Cash Conversion 54.08%
Profit Quality 111.91%
Current Ratio 4.29
Quick Ratio 2.37
Altman-Z 2.55
F-Score6
WACC8.2%
ROIC/WACC0.59
Cap/Depr(3y)36.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.38%
Cap/Sales(5y)N/A
Profit Quality(3y)277.46%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y22.1%
EPS Next 2Y17.47%
EPS Next 3Y16.14%
EPS Next 5YN/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y9.85%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9.77%
Revenue Next 2Y8.72%
Revenue Next 3Y8.38%
Revenue Next 5YN/A
EBIT growth 1Y1.48%
EBIT growth 3Y39.25%
EBIT growth 5YN/A
EBIT Next Year23.05%
EBIT Next 3Y13.44%
EBIT Next 5YN/A
FCF growth 1Y-8.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.41%
OCF growth 3YN/A
OCF growth 5YN/A

MEDLINE INC-CL A / MDLN Fundamental Analysis FAQ

What is the fundamental rating for MDLN stock?

ChartMill assigns a fundamental rating of 5 / 10 to MDLN.


What is the valuation status for MDLN stock?

ChartMill assigns a valuation rating of 4 / 10 to MEDLINE INC-CL A (MDLN). This can be considered as Fairly Valued.


Can you provide the profitability details for MEDLINE INC-CL A?

MEDLINE INC-CL A (MDLN) has a profitability rating of 5 / 10.


What is the valuation of MEDLINE INC-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MEDLINE INC-CL A (MDLN) is 37.45 and the Price/Book (PB) ratio is 5.86.